Centiva Capital’s Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 ANAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,500
Closed -$2K 1977
2022
Q2
$2K Hold
12,500
﹤0.01% 1625
2022
Q1
$4K Hold
12,500
﹤0.01% 1570
2021
Q4
$10K Hold
12,500
﹤0.01% 1128
2021
Q3
$9K Buy
+12,500
New +$10.7K ﹤0.01% 1214

Other funds holding ANAC.WS

Centiva Capital's ANAC.WS Position: Q3 2022 in Review

Centiva Capital sold out of Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (ANAC.WS) in Q3 2022, closing a stake of 12,500 shares — an estimated $2K sold.

Centiva Capital first reported a position in ANAC.WS in Q3 2021 and held it in 4 quarters. The position peaked at $10K in Q4 2021. 49 funds tracked by Wall St. Rank hold ANAC.WS as of Q3 2022.

  • Centiva Capital reported no remaining Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Centiva Capital sold 12,500 Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $2K.
  • Centiva Capital first reported a position in Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 4 quarters.
  • Centiva Capital's Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $10K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.